Wednesday, August 10, 2022
Remember when Republicans and the pharmaceutical industry were friends? The pharmaceutical industry does. Between the lines: Republicans on Capitol Hill barely made a peep last week after the Trump administration rolled out a drug-pricing plan that arguably goes further than the Obama administration ever attempted. This is pharma's second notable...
As we near November's midterm elections, Democrats haven't distilled one of their biggest talking points — Medicare for All — down to one single policy. The big picture: The fight for universal health care is not a new one. But the wave of Democrats campaigning on "Medicare for All" represents the most...
The Trump administration is moving forward with new rules that would require drug companies to disclose their prices, rejecting the industry’s efforts to preempt those regulations. Why it matters: This is the most direct conflict yet between pharmaceutical companies and the administration, and the dispute could quickly escalate into the...
Mary Mayhew, a former health commissioner under Maine Gov. Paul LePage, started yesterday as the director of the federal office that directly oversees Medicaid. Why it matters: The Trump administration is focused intently on reframing Medicaid as something closer to a welfare program, and has arguably made more significant conservative...
By Elizabeth Lucas and Sydney Lupkin 2:00 AM EDT A new Kaiser Health News database tracks campaign donations from drugmakers over the past 10 years. Before the midterm elections heated up, dozens of drugmakers had already poured about $12 million into the war chests of hundreds of members of Congress. Since the...
It may not be long before the world simply doesn’t have many effective antibiotics, according to a scary piece by Maryn McKenna in Wired. The bottom line: “The drugs we have for heart disease, for depression, for cancer, the vaccine for measles—they’ll still work. But antibiotics will be crushed,” Kevin...

Recommended Videos